Fen Xu
- Geriatrics and Gerontology top 2%
- Sirtuins and Resveratrol in Medicine 11
-
- Diet, Metabolism, and Disease 8
- Physiology top 5%
- Adipose Tissue and Metabolism 13
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 16
- Adipokines, Inflammation, and Metabolic Diseases 6
- Hepatology top 10%
-
- Pancreatic function and diabetes 14
-
- Metabolism, Diabetes, and Cancer 9
-
- Endoplasmic Reticulum Stress and Disease 6
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Fen Xu
74 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Geriatrics and Gerontology 197
- Endocrinology, Diabetes and Metabolism 418
- Physiology 414
- Epidemiology 515
- Hepatology 76
Countries citing papers authored by Fen Xu
This map shows the geographic impact of Fen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fen Xu more than expected).
Fields of papers citing papers by Fen Xu
This network shows the impact of papers produced by Fen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fen Xu. The network helps show where Fen Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fen Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 6 | |
| 6 | 2022 | 6 | |
| 7 | 2022 | 8 | |
| 8 | 2022 | 36 | |
| 9 | 2021 | 12 | |
| 10 | 2021 | 5 | |
| 11 | 2020 | 11 | |
| 12 | 2020 | 1 | |
| 13 | 2020 | 29 | |
| 14 | 2020 | 10 | |
| 15 | 2019 | 3 | |
| 16 | 2019 | 34 | |
| 17 | 2018 | 9 | |
| 18 | 2014 | 25 | |
| 19 | 2013 | 10 | |
| 20 | 2010 | 17 |
About Fen Xu
Fen Xu is a scholar working on Geriatrics and Gerontology, Endocrinology, Diabetes and Metabolism and Family Practice, having authored 76 papers that have together received 1.4k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (16 papers), Pancreatic function and diabetes (14 papers), Adipose Tissue and Metabolism (13 papers), Sirtuins and Resveratrol in Medicine (11 papers), Metabolism, Diabetes, and Cancer (9 papers), Diet, Metabolism, and Disease (8 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers) and Endoplasmic Reticulum Stress and Disease (6 papers). The work is most often cited by research in Geriatrics and Gerontology (197 citations), Endocrinology, Diabetes and Metabolism (418 citations) and Physiology (414 citations). Fen Xu has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Jianping Weng, Hua Liang, Mengyin Cai, Jianping Ye, Huanyi Cao, Zonglan Chen, Zhan‐Guo Gao, Jun Yin, Xiaobin Zheng and Chantal A. Rivera. Their work appears in journals such as PLoS ONE, Hepatology and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.